Ceruloplasmin: a copper-containing blood protein

Ceruloplasmin is a copper-containing protein synthesized in the liver and released into the blood after binding copper. It performs two key functions: transporting the majority of circulating copper and participating in iron metabolism as a ferroxidase. According to StatPearls and MedlinePlus, ceruloplasmin binds the majority of copper in the blood, and its hepatic synthesis depends on the normal functioning of hepatocytes and the copper transport system. [1]

The clinical significance of the analysis is primarily associated with copper metabolism disorders. The most common indication is suspected Wilson's disease, a hereditary disorder in which a defect in the ATP7B gene disrupts the incorporation of copper into ceruloplasmin and the excretion of excess copper in bile. As a result, copper accumulates primarily in the liver, brain, cornea, and other tissues. [2]

However, ceruloplasmin is not a "Wilson's disease-only" test. MedlinePlus and Mayo Clinic Laboratories indicate that it is also used in suspected cases of copper deficiency, Menkes disease, and some other copper transport disorders. This makes the test useful, but also requires careful interpretation: the same low result may indicate conditions with different mechanisms. [3]

It's also important to understand the biological properties of ceruloplasmin: it's a positive acute-phase protein. Its levels can rise during inflammation, infection, active hepatitis, pregnancy, and estrogen exposure. Therefore, "normal" or even elevated ceruloplasmin levels don't always reflect normal copper metabolism, but sometimes merely indicate the body's response to inflammation or hormonal conditions. [4]

From a practical standpoint, the test is important not as an isolated answer to the question "is there a disease or not?", but as part of a broader clinical picture. The more the physician knows about the patient's symptoms, age, family history, blood and urine copper levels, the presence of Kayser-Fleischer rings, and genetic results, the more accurately the ceruloplasmin test can be interpreted. This is why modern algorithms are almost never built around this test alone. [5]

Table 1. What ceruloplasmin does and why it is measured

What does the analysis evaluate?	Practical significance
Copper-bound blood protein	helps to understand how the copper transport system works
Indirect copper metabolism status	used when Wilson's disease and other copper disorders are suspected
Ferroxidase system of iron metabolism	helps explain the association with rare iron-storage conditions such as aceruloplasminemia
Acute phase reaction	It is important to remember that inflammation and estrogen can increase the results.
Age-related features	in children, especially under 3 years of age, age references are needed

Table compiled from MedlinePlus, Mayo Clinic Laboratories, ARUP Consult, and StatPearls. [6]

When is the test prescribed and how to donate blood correctly?

The test is most often ordered when Wilson's disease is suspected. Reasons for this may include elevated liver enzymes without a clear cause, chronic hepatitis, cirrhosis at a young age, neurological symptoms, mental changes, Kayser-Fleischer rings, or a family history of Wilson's disease. ARUP and MedlinePlus emphasize that the test is particularly appropriate in patients with early-onset liver or neurological disease and in relatives of an established case. [7]

The second group of indications is related to copper deficiency. MedlinePlus lists malnutrition, malabsorption, zinc excess, and Menkes disease as conditions in which testing can help suspect copper deficiency. In infants with Menkes disease, low ceruloplasmin is considered along with the clinical picture: brittle, light-colored hair, hypotonia, seizures, poor weight gain, and developmental delay. [8]

The third important factor is age. In healthy newborns, ceruloplasmin is physiologically low, then increases in the first 6 months of life and can peak at 2-3 years, sometimes even exceeding adult values. Therefore, a low result in an infant cannot be interpreted using adult ranges. ARUP and GeneReviews specifically emphasize the need for age-specific reference values in pediatrics. [9]

From a laboratory perspective, the analysis is technically straightforward: blood serum is typically used, and nephelometry is a routine method. However, even with accurate measurements, the results should not be interpreted out of context. Ceruloplasmin is not a test that, by itself, confirms or refutes a diagnosis; it merely provides the physician with one of the benchmarks in the diagnostic workup. [10]

Preparation for the test is also important. For a basic ceruloplasmin test, special preparation is usually minimal, but the physician and laboratory should be aware of pregnancy, oral contraceptive use, estrogen use, active infection, severe inflammation, and chronic liver disease, as all of these factors can significantly bias the result upward and make it less diagnostic for copper metabolism disorders. [11]

Table 2. When is ceruloplasmin testing particularly appropriate?

Clinical situation	Why is the test needed?
Unexplained liver disease in a child or young adult	helps to suspect Wilson's disease
Neurological and psychiatric symptoms along with liver abnormalities	is part of the initial search for Wilson's disease
Family history of Wilson's disease	used as part of screening of relatives
Menkes disease suspected in an infant	helps to assess copper transport disorders
Malnutrition, malabsorption, zinc excess	helps identify copper deficiency
Long-term parenteral nutrition without adequate copper	may indicate secondary copper deficiency

Table compiled from MedlinePlus, Mayo Clinic Laboratories, and ARUP Consult. [12]

Table 3. Examples of age- and gender-specific ceruloplasmin reference values according to Mayo Clinic Laboratories

Age	Men	Women
0-8 weeks	7.4-23.7 mg per dL	7.4-23.7 mg per dL
9 weeks - 5 months	13.5-32.9 mg per dL	13.5-32.9 mg per dL
6-11 months	13.7-38.9 mg per dL	13.7-38.9 mg per dL
12 months - 7 years	21.7-43.3 mg per dL	21.7-43.3 mg per dL
14-17 years old	17.0-34.8 mg per dL	20.8-43.2 mg per dL
18 years and older	19.0-31.0 mg per dL	20.0-51.0 mg per dL

This is an example of laboratory intervals, not a universal global norm for all platforms. The table is based on the current form from Mayo Clinic Laboratories. [13]

Low ceruloplasmin: What does it mean and why is it not enough for diagnosis?

Low ceruloplasmin is indeed considered a significant clue to Wilson's disease. ARUP algorithms consider a drop below 20 mg/dL as suspicious, requiring further investigation, and GeneReviews notes that adults with Wilson's disease often have levels below 0.2 g/L and often below 0.1 g/L. However, even this result is not sufficient to confirm the diagnosis. [14]

The reason is that Wilson's disease is not the only condition associated with low ceruloplasmin. MedlinePlus and Mayo Clinic Laboratories list Menkes disease, copper deficiency due to inadequate intake, malabsorption, prolonged copper-depleted parenteral nutrition, zinc excess, and penicillamine therapy as important differential causes. Therefore, a low result requires clinical triage rather than the immediate conclusion, "It's definitely Wilson's disease." [15]

Furthermore, low ceruloplasmin levels occur in protein-losing conditions. Modern reviews describe a decrease in protein-losing enteropathy, nephrotic syndrome, and some forms of renal disease. Low levels have also been described in severe liver failure, when protein synthesis by the liver is impaired. All of this makes the test sensitive but not specific. [16]

A separate rare condition is aceruloplasminemia. GeneReviews describes this disease as a rare autosomal recessive disorder in which a defect in the ceruloplasmin gene causes iron accumulation in the brain and internal organs. The typical clinical triad includes diabetes, retinal degeneration, and neurological disease, and laboratory ceruloplasmin levels may be extremely low or virtually absent. [17]

Finally, even with Wilson's disease itself, low ceruloplasmin isn't found in everyone. GeneReviews emphasizes that normal levels are found in some patients with both neurological and liver forms of the disease. Therefore, a low result isn't a "diagnosis," but rather a signal that further investigation is needed: daily urinary copper, fundus and corneal examination, liver copper, the ATP7B gene, and the overall clinical picture. [18]

Table 4. Main causes of low ceruloplasmin

Cause	What helps to distinguish
Wilson's disease	daily urinary copper, Kayser-Fleischer rings, liver copper, ATP7B gene
Menkes disease	infancy, characteristic hair, severe neurological course
Copper deficiency due to diet	nutritional history, parenteral nutrition, low blood copper
Malabsorption	celiac disease, intestinal diseases, other nutrient deficiencies
Excess zinc	taking zinc supplements or zinc-containing products
Protein-losing enteropathy and nephrotic syndrome	hypoproteinemia, loss of protein through the intestines or kidneys
Severe liver failure	severe impairment of the synthetic function of the liver
Aceruloplasminemia	diabetes, retinopathy, neurology, signs of iron accumulation

The table is compiled from MedlinePlus, Mayo Clinic Laboratories, GeneReviews, and reviews of hypoceruloplasminemia outside of Wilson's disease. [19]

High Ceruloplasmin: Why It Increases and Why It's Important

Elevated ceruloplasmin levels generally do not indicate a copper metabolism disorder per se, but rather reflect an acute phase reaction. StatPearls and Mayo Clinic Laboratories emphasize that ceruloplasmin increases with inflammation, infection, and tissue damage. This means that a high result alone is rarely a diagnostic goal, but it can interfere with test interpretation if Wilson's disease is suspected. [20]

A separate and very important factor is estrogen. Mayo Clinic Laboratories and StatPearls indicate that ceruloplasmin increases during pregnancy, oral contraceptive use, and estrogen-containing therapy. In practice, this means a simple rule: a normal or elevated ceruloplasmin level in a pregnant woman or a patient on estrogen should not automatically reassure the physician if the clinical picture still suggests Wilson's disease. [21]

Elevated ceruloplasmin levels have also been described in active inflammatory diseases, some anemias, pneumonia, tuberculosis, rheumatoid arthritis, hepatitis, and after tissue injury, including myocardial infarction. Mayo cites these conditions as examples of clinical situations in which the level can rise without any direct relation to a primary copper transport defect. [22]

In the context of hepatology, it is also important to note that elevated levels can be found in chronic cholestatic liver diseases. A review of hypoceruloplasminemia outside of Wilson's disease noted that chronic cholestatic disorders, including primary biliary cholangitis and primary sclerosing cholangitis, can be accompanied by increased ceruloplasmin levels. This further demonstrates that the protein is best viewed as an indicator of the overall hepatobiliary inflammatory environment rather than as a precise marker of a single disease. [23]

Thus, a high ceruloplasmin level generally does not require independent "treatment" and does not have the same direct diagnostic value as a persistently low result in the right context. However, it is important precisely as a factor that can mask Wilson's disease and create a false sense of security if the test is evaluated without taking into account inflammation, pregnancy, or hormonal therapy. [24]

Table 5. Common causes of elevated ceruloplasmin

Cause	Why is the level rising?
Acute inflammation	ceruloplasmin is a positive acute phase protein
Infection	the inflammatory response is activated
Pregnancy	estrogens increase the synthesis of ceruloplasmin
Oral contraceptives	the hormonal effect increases concentration
Estrogen therapy	similar mechanism
Active hepatitis	combination of inflammation and liver reaction
Chronic cholestatic liver diseases	possible growth as part of hepatobiliary inflammation
Some anemias and systemic inflammatory diseases	reflection of total acute phase protein

Table compiled from Mayo Clinic Laboratories, StatPearls, and a review of non-Wilsonian hypoceruloplasminemia. [25]

Ceruloplasmin in Wilson's disease: strengths, limitations, and a modern algorithm

In modern Wilson's disease diagnostics, ceruloplasmin retains an important role, but no longer as the sole marker. AASLD, ARUP Consult, and EASL emphasize that diagnosis is based on a combination of clinical data, biochemistry, ophthalmological examination, copper assessment in urine and blood, sometimes liver biopsy, and genetic confirmation. Thus, ceruloplasmin is an important first step, but not the final one. [26]

The strength of the test is that it is often reduced in typical Wilson's disease, especially in patients with neurological manifestations. However, in liver disease patients, the reduction is less consistent, and in some patients, levels remain normal. GeneReviews explicitly states that this test is not suitable for reliable, stand-alone screening. [27]

The method itself also has limitations. A modern review of Wilson's disease notes that many immunological methods measure both copper-rich ceruloplasmin and apoceruloplasmin, a protein without copper. Because of this, the laboratory value does not always perfectly correspond to the biologically active fraction of the protein. This is another reason why the results cannot be taken as absolute. [28]

If ceruloplasmin is low, the next step typically includes 24-hour urinary copper excretion, Kayser-Fleischer rings, free copper assessment, and, in complex cases, liver copper quantification and ATP7B molecular genetic testing. ARUP notes that high liver copper and compatible histology are particularly useful in unclear cases, and the 2025 EASL guidelines specifically emphasize the emerging role of relative exchangeable copper to clarify complex diagnoses. [29]

The practical conclusion is this: ceruloplasmin works best as part of a diagnostic puzzle. A very low result raises suspicion, but a normal result does not resolve the issue. This is why a competent diagnosis of Wilson's disease always relies on a complex, rather than a single, protein. For an article on a medical website, this is a key idea that should not be overlooked. [30]

Table 6. How ceruloplasmin is used in modern Wilson disease testing

Stage	What is being assessed?
Clinical suspicion	liver, neurological, psychiatric symptoms, family history
First laboratory block	ceruloplasmin, blood copper, daily urinary copper, liver function tests
Ophthalmological stage	Kayser-Fleischer rings
Clarification stage	free copper, liver biopsy with quantitative copper
Genetic confirmation	search for pathogenic variants of ATP7B
Modern complex cases	relative exchangeable copper according to the new EASL recommendations

The table is compiled from AASLD, ARUP Consult, GeneReviews and the EASL 2025 New Guidelines Communication. [31]

What does a doctor usually do after a test result is abnormal?

If ceruloplasmin is moderately low and the clinical picture is unclear, the physician should not make a diagnosis based on a single form. Typically, the patient's age, pregnancy status, estrogen intake, signs of nutritional deficiency, bowel disease, excessive zinc intake, protein-losing conditions, and family history are determined first. Such an analysis is often more helpful than a hasty referral to a rare genetic test. [32]

If Wilson disease is suspected, the diagnostic pathway is expanded. ARUP and AASLD recommend a physical examination and ophthalmologic examination for Kayser-Fleischer rings, urinary copper determination, serum copper assessment, and, if necessary, liver biopsy with copper quantification. If the diagnosis is confirmed or highly probable, the next step is genetic evaluation of the patient and family members. [33]

If the clinical picture is more suggestive of copper deficiency, the examination shifts to a different approach. The doctor will inquire about the child's diet, gastrointestinal symptoms, stomach or intestinal surgery, long-term parenteral nutrition, zinc use, and blood copper levels. In infants with a characteristic neurological presentation, Menkes disease is also considered. [34]

With very low ceruloplasmin and Wilson's disease inconsistent with the clinical picture, aceruloplasminemia should be considered. Here, it's appropriate to look not so much at copper levels as at signs of iron metabolism disorders, diabetes, retinopathy, neurological manifestations, and characteristic magnetic resonance imaging findings. This is a rare but fundamentally important differential diagnosis. [35]

If ceruloplasmin is elevated, the course of action is usually determined not by this level, but by the underlying clinical situation. The physician looks for infection, inflammation, active hepatitis, pregnancy, estrogen effects, or cholestasis. Elevated ceruloplasmin alone is rarely a target for specific treatment, but it helps avoid overestimating a "reassuring" result when testing for Wilson's disease. [36]

FAQ

Can ceruloplasmin alone diagnose Wilson's disease?
No. Current guidelines consider ceruloplasmin only as part of a complex diagnosis. Confirming Wilson's disease requires additional data: daily urinary copper levels, Kayser-Fleischer ring testing, sometimes liver copper levels, and genetic testing. [37]

Does a normal ceruloplasmin rule out Wilson's disease?
No. GeneReviews notes that normal levels occur in at least some patients, especially those with liver disease, so the test cannot be considered a reliable stand-alone screening test. [38]

Why can't adult norms be used as a guide for children?
Because ceruloplasmin levels in newborns are physiologically low, rise during the first six months, and by 2-3 years of age can be higher than adult values. Age-specific reference values are needed for children, especially those under 3 years of age. [39]

What are the causes of low ceruloplasmin besides Wilson's disease?
Important causes include Menkes disease, copper deficiency, malabsorption, zinc excess, protein-losing enteropathy, nephrotic syndrome, severe liver failure, and aceruloplasminemia. [40]

Why does ceruloplasmin increase during pregnancy and inflammation?
Because it is a positive acute phase protein, and ceruloplasmin synthesis is also enhanced by estrogen. Therefore, levels rise during inflammation, infection, pregnancy, and oral contraceptive use. [41]

Is a high ceruloplasmin level dangerous in itself?
Usually not. It often reflects an inflammatory or hormonal background, rather than an independent copper metabolism disorder. The clinical significance is determined by the underlying cause of the increase, not the number itself. [42]

Why is urinary copper measured if Wilson's disease is suspected?
Because decreased ceruloplasmin alone is nonspecific. Daily urinary copper reflects excess non-ceruloplasmin copper in circulation and is part of the basic diagnostic algorithm for Wilson's disease. [43]

What's new in the current Wilson's disease guidelines?
The updated 2025 EASL guidelines retain the Leipzig approach to diagnosis but further emphasize the role of relative exchangeable copper as a new parameter for complex diagnostic cases and monitoring. [44]

If ceruloplasmin is very low, does it always indicate Wilson's disease?
No. A very low level greatly increases suspicion, but it should still be evaluated in conjunction with copper, clinical, ophthalmological, and genetic examinations. Furthermore, extremely low values are also possible with aceruloplasminemia. [45]

Should the test be repeated?
Sometimes, yes. A repeat test is useful if there is doubt in the clinical context, if the result contradicts the symptoms, if the patient had the test during an inflammation or pregnancy, or if it is necessary to check the persistence of the decrease before further complex examination. [46]